Current NDC auxiliary source row compounder:800

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 84325-560
Product Ndc: 84325-560
Product Ndc Digits: 84325560
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Nicotinamide Riboside Chloride
Proprietary Name Suffix: [empty]
Nonproprietary Name: Nicotinamide Riboside Chloride
Dosage Form Name: POWDER, FOR SOLUTION
Route Name: INTRAMUSCULAR; INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Willowbend Pharma Select
Establishment Name: Willowbend Pharma Select
Establishment Fei: [empty]
Substance Name: NICOTINAMIDE RIBOSIDE CHLORIDE
Active Ingredients Info: 500 mg/10 mL
History Active Ingredients Raw: NICOTINAMIDE RIBOSIDE CHLORIDE
History Active Ingredients Info Raw: 500 mg/10 mL
History Dosage Raw: POWDER, FOR SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 84325-560-14
Package Ndc: 84325-560-14
Package Ndc Digits: 8432556014
Package Ndc11: 84325056014
Package Description: 1 VIAL in 1 BOX (84325-560-14) > 10 mL in 1 VIAL (84325-560-11)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:800
Source Row Number: 800
Source Row Hash: 1a8802c4d9f7730e53433f61fb476066fccc8ee5e1bce066a2297e9bfd17d663
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR; INTRAVENOUS",
    "PRODUCTNDC": "84325-560",
    "DEASCHEDULE": "",
    "LABELERNAME": "Willowbend Pharma Select",
    "SUBSTANCENAME": "NICOTINAMIDE RIBOSIDE CHLORIDE",
    "DOSAGEFORMNAME": "POWDER, FOR SOLUTION",
    "NDCPACKAGECODE": "84325-560-14",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Nicotinamide Riboside Chloride",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Nicotinamide Riboside Chloride",
    "PACKAGEDESCRIPTION": "1 VIAL in 1 BOX (84325-560-14)  > 10 mL in 1 VIAL (84325-560-11) ",
    "ACTIVEINGREDIENTSINFO": "500 mg/10 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:800
Source Row Number: 800
Status Scope: package
Lookup Ndc: 84325-560-14
Lookup Ndc Digits: 8432556014
Product Ndc: 84325-560
Product Ndc Digits: 84325560
Package Ndc: 84325-560-14
Package Ndc Digits: 8432556014
Package Ndc11: 84325056014
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 1a8802c4d9f7730e53433f61fb476066fccc8ee5e1bce066a2297e9bfd17d663
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51